TLR8 agonist selgantolimod regulates Kupffer cell differentiation status and impairs HBV entry into hepatocytes via an IL-6-dependent mechanism.

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Armando Andres Roca Suarez, Marie-Laure Plissonnier, Xavier Grand, Maud Michelet, Guillaume Giraud, Maria Saez-Palma, Anaëlle Dubois, Sarah Heintz, Audrey Diederichs, Nicolaas Van Renne, Thomas Vanwolleghem, Stephane Daffis, Li Li, Abigail Fosdick, Nikita Kolhatkar, Yao-Chun Hsu, Jeffrey J. Wallin, Audrey Lau, Simon P. Fletcher, Michel Rivoire, Massimo Levrero, Barbara Testoni, Fabien Zoulim.

Journal title: GUT

Journal publisher: BMJ Publishing Group

Published year: 2024

DOI identifier: 10.1136/gutjnl-2023-331396

ISSN: 0017-5749